1. Home
  2. UFPT vs NNNN Comparison

UFPT vs NNNN Comparison

Compare UFPT & NNNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo UFP Technologies Inc.

UFPT

UFP Technologies Inc.

HOLD

Current Price

$190.70

Market Cap

1.5B

Sector

Health Care

ML Signal

HOLD

Logo Anbio Biotechnology Class A Ordinary Shares

NNNN

Anbio Biotechnology Class A Ordinary Shares

HOLD

Current Price

$25.67

Market Cap

1.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
UFPT
NNNN
Founded
1963
2021
Country
United States
Germany
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.5B
1.5B
IPO Year
1996
N/A

Fundamental Metrics

Financial Performance
Metric
UFPT
NNNN
Price
$190.70
$25.67
Analyst Decision
Buy
Analyst Count
2
0
Target Price
$289.00
N/A
AVG Volume (30 Days)
156.9K
20.3K
Earning Date
05-05-2026
04-28-2026
Dividend Yield
N/A
N/A
EPS Growth
15.44
N/A
EPS
8.75
N/A
Revenue
$602,797,000.00
N/A
Revenue This Year
$8.12
N/A
Revenue Next Year
$5.72
N/A
P/E Ratio
$21.95
$446.57
Revenue Growth
19.50
N/A
52 Week Low
$182.87
$5.91
52 Week High
$274.93
$55.65

Technical Indicators

Market Signals
Indicator
UFPT
NNNN
Relative Strength Index (RSI) 37.93 56.03
Support Level $185.32 $19.53
Resistance Level $206.13 $30.70
Average True Range (ATR) 7.89 2.11
MACD 1.51 0.52
Stochastic Oscillator 30.77 71.53

Price Performance

Historical Comparison
UFPT
NNNN

About UFPT UFP Technologies Inc.

UFP Technologies Inc is a contract development and manufacturing organization that specializes in single-use and single-patient medical devices. The company manufactures its products by converting raw materials using laminating, molding, radio frequency, and impulse welding, and fabricating manufacturing techniques. It is an important link in the medical device supply chain and a valued outsource partner to many of the top medical device manufacturers in the world. The company's single-use and single-patient devices and components are used in a wide range of medical devices, disposable wound care products, infection prevention, minimally invasive surgery, wearables, orthopedic soft goods, and orthopedic implant packaging.

About NNNN Anbio Biotechnology Class A Ordinary Shares

Anbio Biotechnology is a medical device company focused on in vitro diagnostics. It offers laboratory, wellness, at-home, and point-of-care (POCT) in vitro diagnostic (IVD) solutions to detect a wide range of biomarkers associated with critical medical domains encompassing infectious diseases, cancer, cardiovascular diseases, inflammation, drug abuse, endocrine disorders, renal disease, pharmacogenomics, and diabetes. Its product portfolio comprises AF-1200 Fluorescence Immunoassay Analyzer, SHA-100 Dry Chemistry Analyzer, Ferritin Rapid Test Kit, Dengue NS1 Rapid Test, Multi-HBV Rapid Test, COVID-19 Test Kit (Real-time PCR), and others. Geographically, the company generates maximum revenue from the European Union, followed by South America, Asia Pacific, North America, and other regions.

Share on Social Networks: